PBRM1 and nonpapillary renal cell carcinoma: However, the relationship between PBRM1 status and prognosis appears complex, as some reports suggest ccRCC patients with PBRM1 inactivation may have a better prognosis compared to those with other mutations- seemingly contradicting the association between elevated LTR-driven HERV expression and poor outcomes [110, 114, 115].